Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Abbott beats forecasts as drug sales shine
Yahoo/Reuters
Wednesday, January 26, 2011 - 10:49am
tags:
earnings, Abbott Laboratories, JNJ, Solvay
Decent Quarter for Dr. Reddy's
Yahoo/Zacks.com
Wednesday, January 26, 2011 - 10:47am
tags:
Dr Reddy's, earnings, AstraZeneca
Abbott Cuts 1,900 Jobs in Restructuring of Drug Unit
Bloomberg
Wednesday, January 26, 2011 - 10:46am
tags:
layoffs, Abbott Laboratories
Sanofi CEO Says Genzyme Progress Made, Still Some Differences
Bloomberg
Wednesday, January 26, 2011 - 8:06am
tags:
Sanofi, Genzyme, M&A, Pharma CEOs, Chris Viehbacher
Johnson & Johnson: Pullback Presents Buy Opportunity
Seeking Alpha
Wednesday, January 26, 2011 - 8:04am
tags:
JNJ
Will Depomed Get Past the FDA?
Motley Fool
Wednesday, January 26, 2011 - 8:03am
tags:
FDA, Depomed, DM-1796, shingles
FDA Approves Allegra Sale Without Prescription
WSJ Online
Tuesday, January 25, 2011 - 6:04pm
tags:
FDA, Allegra, allergies, Sanofi
Gilead's HIV Drug: FDA Returns to Sender
TheStreet.com
Tuesday, January 25, 2011 - 6:03pm
tags:
HIV, FDA, Gilead Sciences, B-tripla
Earnings Preview: Bristol-Myers to report 4Q
Yahoo/AP
Tuesday, January 25, 2011 - 2:08pm
tags:
earnings, Bristol-Myers Squibb
Does This Mean Merck Will Burn You?
Motley Fool
Tuesday, January 25, 2011 - 2:07pm
tags:
Merck
Bristol-Myers Squibb, Sanofi-Aventis Get Plavix Extension
Bloomberg
Tuesday, January 25, 2011 - 2:07pm
tags:
Plavix, Bristol-Myers Squibb, Sanofi, patents
Inhaled Insulin Maker Still Breathing - MannKind’s future may hinge on deep pockets of owner
LA Business Journal, CA
Tuesday, January 25, 2011 - 12:03pm
tags:
MannKind, inhaled insulin, diabetes, Afrezza
Should Whistleblower Payments Have A Cap?
Pharmalot
Tuesday, January 25, 2011 - 12:00pm
tags:
whistleblowers
Earnings Preview: Eli Lilly
Yahoo/Zacks.com
Tuesday, January 25, 2011 - 11:26am
tags:
Eli Lilly, earnings
Boost for VRX-GSK Epilepsy Drug
Yahoo/Zacks.com
Tuesday, January 25, 2011 - 11:07am
tags:
epilepsy, GSK, JNJ, Pfizer, Valeant Pharmaceuticals, Europe, retigabine
Glaxo Exec Wants To Know ‘What Went Wrong?’
Pharmalot
Tuesday, January 25, 2011 - 11:06am
tags:
GSK
Eisai’s Severe Sepsis Drug Fails in Final-Stage Study
Bloomberg
Tuesday, January 25, 2011 - 11:04am
tags:
Eisai, sepsis, eritoran
BioSante rallies on FDA move for melanoma vaccine
Marketwatch
Tuesday, January 25, 2011 - 10:48am
tags:
FDA, BioSante, vaccines, melanoma
Savient Names Lilly’s John Johnson Chief Executive
Bloomberg
Tuesday, January 25, 2011 - 10:46am
tags:
Savient, Eli Lilly, John Johnson
J&J reports lower 4Q profit, revenue
Yahoo/AP
Tuesday, January 25, 2011 - 9:32am
tags:
earnings, JNJ

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.